These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4187630)

  • 1. Unusual thyroid-stimulating activity in the plasma of a man with choriocarcinoma.
    Winland R; Bates R; Becker CE; Rosen SW
    J Clin Endocrinol Metab; 1969 Oct; 29(10):1369-72. PubMed ID: 4187630
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma thyrotropic activity in a man with choriocarcinoma.
    Orgiazzi J; Rousset B; Cosentino C; Tourniaire J; Dutrieux N
    J Clin Endocrinol Metab; 1974 Oct; 39(4):653-7. PubMed ID: 4472238
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonogenesis in thyroid neoplasms].
    Valenta L; Lemarchand-Béraud T; Vannotti A; Silink K
    Schweiz Med Wochenschr; 1968 Jan; 98(4):101-10. PubMed ID: 5670492
    [No Abstract]   [Full Text] [Related]  

  • 4. The need for more sensitive assays for the measurement of thyroid-stimulating hormone (TSH) and the long-acting thyroid stimulator (LATS).
    Hall R
    Clin Endocrinol (Oxf); 1974 Jul; 3(3):361-2. PubMed ID: 4837955
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperthyroidism induced by trophoblastic thyrotropin.
    Hershman JM
    Mayo Clin Proc; 1972 Dec; 47(12):913-8. PubMed ID: 4346220
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation of long acting thyroid stimulator (LATS) and thyroid stimulating hormone (TSH) in the serum].
    Ochi Y; Shiomi K; Yatani T; Yoshimura M; Miyazaki T
    Horumon To Rinsho; 1973 Jan; 21(1):49-52. PubMed ID: 4736415
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyrotoxicosis from molar thyrotropin.
    Karp PJ; Hershman JM; Richmond S; Goldstein DP; Selenkow HA
    Arch Intern Med; 1973 Sep; 132(3):432-6. PubMed ID: 4361214
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation of the cytochemical section bioassay for thyroid stimulators and its application to the measurement of thyroid-stimulating antibodies [proceedings].
    Ealey PA; Smyth PP
    J Endocrinol; 1979 May; 81(2):113P-114P. PubMed ID: 222863
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the biological effect of the thyrotropic activity of the blood of diffuse toxic goiter patients].
    Baranov VG; Potin VV; Stepanov GS; Shliakhtina LG
    Probl Endokrinol (Mosk); 1970; 16(6):27-33. PubMed ID: 4106950
    [No Abstract]   [Full Text] [Related]  

  • 10. Choriocarcinoma with hyperthyroidism: probable identity of the thyrotropin with human chorionic gonadotropin.
    Cave WT; Dunn JT
    Ann Intern Med; 1976 Jul; 85(1):60-3. PubMed ID: 945709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyroid stimulating substances in human saliva.
    Sahadevan V; Field EO
    Strahlentherapie Sonderb; 1968; 67():425-35. PubMed ID: 4180681
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 14. [Colic localization of a choriocarcinoma in a man with a triple endocrine syndrome: gynecomastia, hyperthyroidism and hypercortisolism].
    Cosentino C; Orgiazzi J; Bertrand JL; Tran-Minh V; Brette R
    Lyon Med; 1972 Mar; 227(6):553-60. PubMed ID: 4538274
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.
    Adams DD; Kennedy TH; Stewart JC; Utiger RD; Vidor GI
    J Clin Endocrinol Metab; 1975 Aug; 41(2):221-8. PubMed ID: 51028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
    Gharib H; Mayberry WE
    Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
    Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
    J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
    [No Abstract]   [Full Text] [Related]  

  • 18. [Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
    Földes J; Gesztesi E; Takács I
    Orv Hetil; 1970 Dec; 111(52):3067-70. PubMed ID: 4099957
    [No Abstract]   [Full Text] [Related]  

  • 19. An improved bio-assay for the determination of long-acting thyroid stimulator (LATS).
    Ason EK; Hetzel BS; Good BF; Stenhouse NS
    J Clin Endocrinol Metab; 1967 Nov; 27(11):1529-39. PubMed ID: 6075584
    [No Abstract]   [Full Text] [Related]  

  • 20. A modification of the McKenzie bioassay for long-acting thyroid stimulator (LATS).
    Shishiba Y; Solomon DH
    J Clin Endocrinol Metab; 1969 Mar; 29(3):405-8. PubMed ID: 5773076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.